"Vesicular Stomatitis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A viral disease caused by at least two distinct species (serotypes) in the VESICULOVIRUS genus: VESICULAR STOMATITIS INDIANA VIRUS and VESICULAR STOMATITIS NEW JERSEY VIRUS. It is characterized by vesicular eruptions on the ORAL MUCOSA in cattle, horses, pigs, and other animals. In humans, vesicular stomatitis causes an acute influenza-like illness.
Descriptor ID |
D054243
|
MeSH Number(s) |
C02.782.580.830.825 C07.465.864.968 C22.952
|
Concept/Terms |
Vesicular Stomatitis- Vesicular Stomatitis
- Stomatitides, Vesicular
- Vesicular Stomatitides
- Stomatitis, Vesicular
|
Below are MeSH descriptors whose meaning is more general than "Vesicular Stomatitis".
Below are MeSH descriptors whose meaning is more specific than "Vesicular Stomatitis".
This graph shows the total number of publications written about "Vesicular Stomatitis" by people in this website by year, and whether "Vesicular Stomatitis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2015 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
2021 | 2 | 0 | 2 |
2022 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vesicular Stomatitis" by people in Profiles.
-
Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease. Front Immunol. 2023; 14:1216225.
-
Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential. PLoS Pathog. 2022 06; 18(6):e1010658.
-
Transcriptomic signatures induced by the Ebola virus vaccine rVSV?G-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study. Lancet Microbe. 2022 02; 3(2):e113-e123.
-
High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission. Emerg Microbes Infect. 2021 Dec; 10(1):651-663.
-
Transient blockade of TBK1/IKKe allows efficient transduction of primary human natural killer cells with vesicular stomatitis virus G-pseudotyped lentiviral vectors. Cytotherapy. 2021 09; 23(9):787-792.
-
Comparative evaluation of pathogenicity of three isolates of vesicular stomatitis virus (Indiana serotype) in pigs. J Gen Virol. 2019 11; 100(11):1478-1490.
-
Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector species. Hum Vaccin Immunother. 2018 04 03; 14(4):994-1002.
-
Soluble interleukin-15 complexes are generated in vivo by type I interferon dependent and independent pathways. PLoS One. 2015; 10(3):e0120274.
-
Translational control of the activation of transcription factor NF-?B and production of type I interferon by phosphorylation of the translation factor eIF4E. Nat Immunol. 2012 Apr 29; 13(6):543-550.
-
Regulation of antiviral innate immunity by deubiquitinase CYLD. Cell Mol Immunol. 2011 Nov; 8(6):502-4.